Gen Lin

1.5k citations

64 papers · 537 indexed · h-index 12

Impact in

Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Cancer Research
- Cancer Genomics and Diagnostics

Papers in ⓘ

Cancer Research 21
- Cancer Genomics and Diagnostics 12
Oncology 37
- Colorectal Cancer Treatments and Studies 11
- Lung Cancer Research Studies 10
- Cancer Immunotherapy and Biomarkers 9
- Cancer Cells and Metastasis 5

Co-authors: Qian Miao (11 shared papers)Kan Jiang (14 shared papers)Haipeng Xu (14 shared papers)Cheng Huang (8 shared papers)Zhiyong He (2 shared papers)Xiandong Lin (5 shared papers)Dan Hu (3 shared papers)Yunjian Huang (9 shared papers)
Journals: Journal of Clinical Oncology (19 papers)Journal of Thoracic Oncology (6 papers)Annals of Oncology (3 papers)Scientific Reports (2 papers)Annals of Palliative Medicine (2 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Gen Lin

54 papers receiving 530 citations

Peers

Countries citing papers authored by Gen Lin

Since Specialization

Citations

This map shows the geographic impact of Gen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gen Lin more than expected).

Fields of papers citing papers by Gen Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gen Lin. The network helps show where Gen Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Gen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gen Lin Line = papers co-authored together Gen Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer Oncotarget ·Gen Lin, Xirong Fan, Weifeng Zhu, Cheng Huang, Wu Zhuang, Haipeng Xu, Xiandong Lin, Dan Hu, Yunjian Huang, Kan Jiang, Qian Miao, Chao Li	2017	73
2	Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer Journal of Thoracic Oncology ·Chao Li, Cheng Huang, Tony Mok, Wu Zhuang, Haipeng Xu, Qian Miao, Xirong Fan, Weifeng Zhu, Yunjian Huang, Xiandong Lin, Kan Jiang, Dan Hu, Xiaohui Chen, Peisha Huang, Gen Lin	2017	46
3	KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples Translational Lung Cancer Research ·Herbert H. Loong, Nan Du, Chunyan Cheng, Hanqing Lin, Jian Guo, Gen Lin, Mingjiang Li, Tao Jiang, Zhihua Shi, Yanzhi Cui, Xianfeng Jin, Jicheng Yao, Yutong Xing, Ming Yao, Kai Wang, Tony Mok, Lunxu Liu	2020	42
4	Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy PLoS ONE ·Yu Chen, Gen Lin, Zengqing Guo, Zhifeng Zhou, Zhiyong He, Yunbin Ye	2013	40
5	Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer Scientific Reports ·Haipeng Xu, Gen Lin, Cheng Huang, Weifeng Zhu, Qian Miao, Xirong Fan, Wu B, Xiaobing Zheng, Xiandong Lin, Kan Jiang, Dan Hu, Chao Li	2017	36
6	Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib Lung Cancer ·Jun Zhao, Gen Lin, Minglei Zhuo, Zaiwen Fan, Liyun Miao, Likun Chen, Aiping Zeng, Rong Yin, Yangming Ou, Zhihui Shi, Jie Yin, Wen Gao, Jianhua Chen, Xiangdong Zhou, Yong Zeng, Xiang Liu, Huamin Xu, Rongrong Chen, Xuefeng Xia, David P. Carbone	2019	30
7	siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells Oncology Reports ·Zhiyong He, Chuanzhong Huang, Gen Lin, Yunbin Ye	2016	28
8	The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer Cancer Medicine ·Hanxiao Chen, Dingzhi Huang, Gen Lin, Xue Yang, Minglei Zhuo, Yujia Chi, Xiaoyu Zhai, Bo Jia, Jingjing Wang, Yuyan Wang, Jianjie Li, Tongtong An, Meina Wu, Ziping Wang, Jun Zhao	2022	19
9	Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 Gu Hh, Kan Saito, Lori D. Klaman, Shen Jq, Tony Fleming, Y. Wang, Joanne C. Pratt, Gen Lin, B. S. Lim, Jean‐Pierre Kinet, Benjamin G. Neel	2001	19
10	KRAS Mutation and NF-κB Activation Indicates Tolerance of Chemotherapy and Poor Prognosis in Colorectal Cancer Digestive Diseases and Sciences ·Gen Lin, Xiongwei Zheng, Chao Li, Qiang Chen, Yunbin Ye	2012	17
11	Comparison of the c‐MET gene amplification between primary tumor and metastatic lymph nodes in non‐small cell lung cancer Thoracic Cancer ·C. Xu, Wenxian Wang, Meijuan Wu, You‐cai Zhu, Wu Zhuang, Gen Lin, Kaiqi Du, Yun‐jian Huang, Yanping Chen, Gang Chen, Meiyu Fang	2017	17
12	Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis Genes ·Jinrong Liao, Chen Zeng, Xingguang Luο, Ying Su, Tao Huang, Haipeng Xu, Keyu Lin, Qianlan Zheng, Lurong Zhang, Gen Lin, Xiandong Lin	2022	12
13	Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer Journal of Cellular and Molecular Medicine ·Gen Lin, Chao Li, Cheng Huang, Wu Zhuang, Yunjian Huang, Haipeng Xu, Qian Miao, Dan Hu	2018	11
14	Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis Annals of Palliative Medicine ·Qian Miao, Xiaobin Zheng, Longfeng Zhang, Kan Jiang, Wu B, Gen Lin	2020	11
15	Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study European Journal of Cancer ·Wenxian Wang, Gen Lin, Yue Hao, Yelan Guan, Yuxin Zhang, C. Xu, Qian Wang, Dong Wang, Zhansheng Jiang, Jing Cai, Guangyuan Lou, Zhengbo Song, Yongchang Zhang	2022	10
16	High expression of AlkB homolog 5 suppresses the progression of non‐small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11 Environmental Toxicology ·Zhangzhou Huang, Gen Lin, Yaping Hong, Lihong Weng, Kai Zhu, Wu Zhuang	2024	10
17	Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People’s Republic of China JTO Clinical and Research Reports ·Rui Fu, Lin Wu, Chao Zhang, Qian Chu, Jie Hu, Gen Lin, Lin Yang, Jisheng Li, Xue‐Ning Yang, Jin‐Ji Yang, Qing Zhou, Yi‐Long Wu, Wen‐Zhao Zhong	2020	9
18	Effects of micro‐amounts of Porphyromonas gingivalis lipopolysaccharide on rabbit inflammatory immune response and development of atherosclerosis Journal of Periodontal Research ·Gen Lin, Xiulin Shi, S. Chen, Lang Lei, Xiaoqing You, Min Huang, Lan Luo, Yunfei Li, Xin Zhao, Fuhua Yan	2014	8
19	Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance Oncology Letters ·Kunshou Zhu, Yujie Deng, Guoxing Weng, Dan Hu, Cheng Huang, Keitaro Matsumoto, Takeshi Nagayasu, Takehiko Koji, Xiongwei Zheng, Wenhui Jiang, Gen Lin, Yibin Cai, Guibin Weng, Xiaohui Chen	2018	8
20	1379P Preliminary results of phase II KUNPENG study of vebreltinib in patients (Pts) with advanced NSCLC harboring c-MET alterations Annals of Oncology ·J-J. Yang, Yalin Zhang, Lin Wu, Jianwei Hu, Wang Zh, Chen Jh, Yun Fan, Gen Lin, Q-M. Wang, Yu Yao, Jun Zhao, Y. Chen, Jian Fang, Yong Song, Weidong Zhang, Ying Cheng, R-H. Guo, X-Y. Li, Anhong Li, Yi‐Long Wu	2023	7

About Gen Lin

Gen Lin is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Immunology and Neurology, having authored 64 papers that have together received 537 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Research Studies (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Cells and Metastasis (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Oncology (309 citations), Cancer Research (127 citations), Pulmonary and Respiratory Medicine (251 citations), Immunology (120 citations) and Molecular Biology (163 citations). Gen Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qian Miao, Kan Jiang, Haipeng Xu, Cheng Huang, Zhiyong He, Xiandong Lin, Dan Hu, Yunjian Huang, Weifeng Zhu and Yunbin Ye. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Scientific Reports and Annals of Palliative Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact